![Rank: 7](static/image/common/star_level3.gif) ![Rank: 7](static/image/common/star_level2.gif) ![Rank: 7](static/image/common/star_level1.gif)
- 现金
- 3700 元
- 精华
- 16
- 帖子
- 1790
- 注册时间
- 2002-12-9
- 最后登录
- 2021-4-14
|
2楼
发表于 2004-8-5 03:39
4 参考文献
1 Kane M. Global status of hepatitis B immunization. Lancet 1996;348:696
2 Fattovich G. Natural history and prognosis of hepatitis B. Semin Liver Dis 2003;23:47-58
3 Delaney WE 4th, Locarnini S, Shaw T. Resistance of hepatitis B virus to antiviral drugs: current aspects and directions
for future investigation. Antivir Chem Chemother 2001;12:1-35
4 Delaney W 4th, Bartholomeusz A, Locarnini SA. Evolving therapies for the treatment of chronic hepatitis B virus infection.
Expert Opin Investig Drugs 2002;11:169-187
5 Karayiannis P. Hepatitis B virus: old, new and future approaches to antiviral treatment. J Antimicrob Chemother
2003;51:761-785
6 Hu J, Toft D, Seeger C. Hepadnavirus assembly and reverse transcription require a multi-component chaperone complex
which is incorporated into nucleocapids. EMBO J 1997;16:59-68
7 Nassal M, Schaller H. Hepatitis B virus replication-an update. J Viral Hepatitis 1996;3:217-226
8 Guidotti LG, Rochford R, Chung J, Shapiro M, Purcell R, Chisari FV. Viral clearance without destruction of infected cells
during acute HBV infection. Science 1999;284:825-829
9 Guidotti LG, Chisari FV. Noncytolytic control of viral infections by the innate and adaptive immune response. Annu Rev
Immunol 2001;19:65-91
10 Wieland SF, Guidotti LG, Chisari FV. Intrahepatic induction of alpha/beta interferon eliminates viral RNA-containing
capsids in hepatitis B virus transgenic mice. J Virol 2000;74:4165-4173
11 Wieland SF, Vega RG, Muller R, Evans CF, Hilbush B, Guidotti LG, Sutcliffe JG, Schultz PG, Chisari FV. Searching for
interferon-induced genes that inhibit hepatitis B virus replication in transgenic mouse hepatocytes. J Virol
2003;77:1227-1236
12 Diepolder HM, Ries G, Jung MC, Schlicht HJ, Gerlach JT, Gr ner N, Caselmann WH, Pape GR. Differential antigen-
processing pathways of the hepatitis B virus e and core proteins. Gastroenterology 1999;116:650-657
13 Milich DR. Do T cells “see” the hepatitis B core and e antigens differently? Gastroenterology 1999;116:765-768
14 Guo JT, Zhou H, Liu C, Aldrich C, Saputelli J, Whitaker T, Barrasa MI, Mason WS, Seeger C. Apoptosis and regeneration
of hepatocytes during recovery from transient hepadnavirus infections. J Virol 2000;74:1495-1505
15 Kajino K, Jilbert AR, Saputelli J, Aldrich CE, Cullen J, Mason WS. Woodchuck hepatitis virus infections: very rapid
recovery after a prolonged viremia and infection of virtually every hepatocyte. J Virol 1994;68:5792-5803
16 Boni C, Bertoletti A, Penna A, Cavalli A, Pilli M, Urbani S, Scognamiglio P, Boehme R, Panebianco R, Fiaccadori F,
Ferrari C. Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B. J Clin Invest
1998;102:968-975
17 Lanford RE, Notvall L, Beames B. Nucleotide priming and reverse transcriptase activity of hepatitis B virus polymerase
expressed in insect cells. J Virol 1995;69:4431-4439
18 King RW, Ladner SK, Miller TJ, Zaifert K, Perni RB, Conway SC, Otto MJ. Inhibition of human hepatitis B virus replication
by AT-61, a phenylpropenamide derivative, alone and in combination with (-) beta-L-2’, 3’-dideoxy-3’-thiacytidine.
Antimicrob Agents Chemother 1998;42:3179-3186
19 Delaney WE 4th, Edwards R, Colledge D, Shaw T, Furman P, Painter G, Locarnini S. Phenylpropenamide derivatives
AT-61 and AT-130 inhibit replication of wild-type and lamivudine-resistant strains of hepatitis B virus in vitro.
Antimicrob Agents Chemother 2002;46:3057-3060
20 Feid J, College D, Sozzi T. The phenylpropenamide derivative AT-130 inhibits HBV replication at viral encapisdation
and packaging. Hepatology 2002;36:300A
21 Deres K, Schroder CH, Paessens A, Goldmann S, Hacker HJ, Weber O, Kramer T, Niewohner U, Pleiss U, Stoltefuss J,
Graef E, Koletzki D, Masantschek RN, Reimann A, Jaeger R, Gross R, Beckermann B, Schlemmer KH, Haebich D,
Rubsamen-Waigmann H. Inhibition of hepatitis B virus replication by drug-induced depletion of nucleocapsids. Science
2003;299:893-896
22 Kamiya N, Kubota A, Iwase Y, Sekiya K, Ubasawa M, Yuasa S. Antiviral activities of MCC-478, a novel and specific
inhibitor of hepatitis B virus. Antimicrob Agents Chemother 2002;46:2872-2877
23 Branch AD. A hitchhiker’s guide to antisense and nonantisense biochemical pathways. Hepatology 1996;24:1517-1529
24 Hannon GJ. RNA interference. Nature 2002;418:244-251
25 Randall G, Grakoui A, Rice CM. Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering
RNAs. Proc Natl Acad Sci USA 2003;100:235-240
26 Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H. Interleukin-18 regulates both Th1 and Th2 responses. Annu Rev
Immunol 2001;19:423-474
27 Kimura K, Kakimi K, Wieland S, Guidotti LG, Chisari FV. Interleukin-18 inhibits hepatitis B virus replication in the livers
of transgenic mice. J Virol 2002;76:10702-10707
28 Rossol S, Marinos G, Carucci P, Singer MV, Williams R, Naoumov NV. Interleukin-12 induction of Th1 cytokines is
important for viral clearance in chronic hepatitis B. J Clin Invest 1997;99:3025-3033
29 Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998;392:245-252
30 Beckebaum S, Cicinnati VR, Dworacki G, Muller-Berghaus J, Stolz D, Harnaha J, Whiteside TL, Thomson AW, Lu L,
Fung JJ, Bonham CA. Reduction in the circulating pDC1/pDC2 ratio and impaired function of ex vivo-generated DC1 in
chronic hepatitis B infection. Clin Immunol 2002;104:138-150
31 Nestle FO, Banchereau J, Hart D. Dendritic cells: On the move from bench to bedside. Nat Med 2001;7:761-765
32 Shimizu Y, Guidotti LG, Fowler P, Chisari FV. Dendritic cell immunization breaks cytotoxic T lymphocyte tolerance in
hepatitis B virus transgenic mice. J Immunol 1998;161:4520-4529
33 You Z, Huang XF, Hester J, Rollins L, Rooney C, Chen SY. Induction of vigorous helper and cytotoxic T cell as well as B
cell responses by dendritic cells expressing a modified antigen targeting receptor-mediated internalization pathway.
J Immunol 2000;165:4581-4591
|
|